Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes.

Dermatology and therapy·2025
Same author

Insights into Lichen Planus Pigmentosus Inversus using Minimally Invasive Dermal Patch and Whole Transcriptome Analysis.

Journal of clinical and investigative dermatology·2022
Same author

Minimally Invasive Skin Transcriptome Extraction Using a Dermal Biomarker Patch.

Dermatology and therapy·2022
Same author

Effects of α-pyrrolidino-phenone cathinone stimulants on locomotor behavior in female rats.

Drug and alcohol dependence·2021
Same author

A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm.

Dermatology and therapy·2021
Same author

Binge-like acquisition of α-pyrrolidinopentiophenone (α-PVP) self-administration in female rats.

Psychopharmacology·2018

Related Experiment Video

Updated: Jan 6, 2026

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.9K

High-throughput screening technologies for botulinum neurotoxins.

Kristin M Bompiani, Tobin J Dickerson1

  • 1Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, SP30- 3040, La Jolla, CA, 92037, USA. tobin@scripps.edu.

Current Topics in Medicinal Chemistry
|October 23, 2014
PubMed
Summary

Botulinum neurotoxins (BoNTs), potent toxins causing paralysis, are a biowarfare concern. High-throughput screening (HTS) identifies new diagnostic and therapeutic agents for botulism.

More Related Videos

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.5K
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.7K

Related Experiment Videos

Last Updated: Jan 6, 2026

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.9K
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.5K
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.7K

Area of Science:

  • Microbiology
  • Toxicology
  • Biotechnology

Background:

  • Botulinum neurotoxins (BoNTs) are the most potent known toxins, causing paralysis and potentially death.
  • BoNTs pose significant biowarefare risks due to their toxicity and limited treatment options.
  • Current antitoxin stockpiles are finite, necessitating the development of novel detection and therapeutic strategies.

Purpose of the Study:

  • To review existing high-throughput screening (HTS) platforms for identifying novel BoNT diagnostic or therapeutic agents.
  • To discuss the application of HTS in discovering new molecules for botulism detection and treatment.
  • To summarize the progress of identified compounds from HTS efforts.

Main Methods:

  • Review of high-throughput screening (HTS) platforms.
  • Analysis of HTS applications for antibodies, peptides, small molecules, and aptamers.
  • Evaluation of screening results and compound progress.

Main Results:

  • Various HTS platforms have been successfully applied to screen for BoNT-targeting molecules.
  • Identified compounds include antibodies, peptides, small molecules, and aptamers with diagnostic or therapeutic potential.
  • Progress in the development of these identified agents is ongoing.

Conclusions:

  • High-throughput screening (HTS) is a valuable approach for discovering novel agents against botulinum neurotoxins (BoNTs).
  • The identified molecules show promise for improved botulism diagnostics and therapeutics.
  • Continued research and development are crucial for addressing BoNT threats.